|
1
|
Ciechanover A: The ubiquitin-proteasome
pathway: On protein death and cell life. EMBO J. 17:7151–7160.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ciechanover A and Schwartz AL: The
ubiquitin-proteasome pathway: The complexity and myriad functions
of proteins death. Proc Natl Acad Sci USA. 95:2727–2730. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hershko A: The ubiquitin system for
protein degradation and some of its roles in the control of the
cell division cycle. Cell Death Differ. 12:1191–1197. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hershko A and Ciechanover A: The ubiquitin
system. Annu Rev Biochem. 67:425–479. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu YC, Pan J, Zhang C, Fan W, Collinge M,
Bender JR and Weissman SM: A MHC-encoded ubiquitin-like protein
(FAT10) binds noncovalently to the spindle assembly checkpoint
protein MAD2. Proc Natl Acad Sci USA. 96:4313–4318. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gunawardena HP, Huang Y, Kenjale R, Wang
H, Xie L and Chen X: Unambiguous characterization of site-specific
phosphorylation of leucine-rich repeat Fli-I-interacting protein 2
(LRRFIP2) in Toll-like receptor 4 (TLR4)-mediated signaling. J Biol
Chem. 286:10897–10910. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hochstrasser M: Origin and function of
ubiquitin-like proteins. Nature. 458:422–429. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bawa-Khalfe T and Yeh ET: SUMO losing
balance: SUMO proteases disrupt SUMO homeostasis to facilitate
cancer development and progression. Genes Cancer. 1:748–752. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rao-Naik C, delaCruz W, Laplaza JM, Tan S,
Callis J and Fisher AJ: The rub family of ubiquitin-like proteins.
Crystal structure of Arabidopsis rub1 and expression of multiple
rubs in Arabidopsis. J Biol Chem. 273:34976–34982. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Whitby FG, Xia G, Pickart CM and Hill CP:
Crystal structure of the human ubiquitin-like protein NEDD8 and
interactions with ubiquitin pathway enzymes. J Biol Chem.
273:34983–34991. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kamitani T, Kito K, Nguyen HP and Yeh ET:
Characterization of NEDD8, a developmentally down-regulated
ubiquitin-like protein. J Biol Chem. 272:28557–28562. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim DY, Kwon E, Hartley PD, Crosby DC,
Mann S, Krogan NJ and Gross JD: CBFβ stabilizes HIV Vif to
counteract APOBEC3 at the expense of RUNX1 target gene expression.
Mol Cell. 49:632–644. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hori T, Osaka F, Chiba T, Miyamoto C,
Okabayashi K, Shimbara N, Kato S and Tanaka K: Covalent
modification of all members of human cullin family proteins by
NEDD8. Oncogene. 18:6829–6834. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Salon C, Brambilla E, Brambilla C,
Lantuejoul S, Gazzeri S and Eymin B: Altered pattern of Cul-1
protein expression and neddylation in human lung tumours:
Relationships with CAND1 and cyclin E protein levels. J Pathol.
213:303–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chairatvit K and Ngamkitidechakul C:
Control of cell proliferation via elevated NEDD8 conjugation in
oral squamous cell carcinoma. Mol Cell Biochem. 306:163–169. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Raasi S, Schmidtke G and Groettrup M: The
ubiquitin-like protein FAT10 forms covalent conjugates and induces
apoptosis. J Biol Chem. 276:35334–35343. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan W, Cai W, Parimoo S, Schwarz DC,
Lennon GG and Weissman SM: Identification of seven new human MHC
class I region genes around the HLA-F locus. Immunogenetics.
44:97–103. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL,
Tan S Yong, Kan A, Nuchprayoon I, Jin R, Lee KH, et al: Expression
of the FAT10 gene is highly upregulated in hepatocellular carcinoma
and other gastrointestinal and gynecological cancers. Oncogene.
22:2592–2603. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Soucy TA, Dick LR, Smith PG, Milhollen MA
and Brownell JE: The NEDD8 conjugation pathway and its relevance in
cancer biology and therapy. Genes Cancer. 1:708–716. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Richardson PG, Sonneveld P, Schuster MW,
Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D,
Lonial S, Goldschmidt H, et al: Bortezomib or high-dose
dexamethasone for relapsed multiple myeloma. N Engl J Med.
352:2487–2498. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
San Miguel JF, Schlag R, Khuageva NK,
Dimopoulos MA, Shpilberg O, Kropff M, Spicka I, Petrucci MT,
Palumbo A, Samoilova OS, et al: Bortezomib plus melphalan and
prednisone for initial treatment of multiple myeloma. N Engl J Med.
359:906–917. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kane RC, Dagher R, Farrell A, Ko CW,
Sridhara R, Justice R and Pazdur R: Bortezomib for the treatment of
mantle cell lymphoma. Clin Cancer Res. 13:5291–5294. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Y, Kitagaki J, Dai RM, Tsai YC,
Lorick KL, Ludwig RL, Pierre SA, Jensen JP, Davydov IV, Oberoi P,
et al: Inhibitors of ubiquitin-activating enzyme (E1), a new class
of potential cancer therapeutics. Cancer Res. 67:9472–9481. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao Y, Xiong X, Jia L and Sun Y:
Targeting Cullin-RING ligases by MLN4924 induces autophagy via
modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis. Cell Death Dis.
3:e3862012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kamitani T, Kito K, Fukuda-Kamitani T and
Yeh ET: Targeting of NEDD8 and its conjugates for proteasomal
degradation by NUB1. J Biol Chem. 276:46655–46660. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kito K, Yeh ET and Kamitani T: NUB1, a
NEDD8-interacting protein, is induced by interferon and
down-regulates the NEDD8 expression. J Biol Chem. 276:20603–20609.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tanaka T, Kawashima H, Yeh ET and Kamitani
T: Regulation of the NEDD8 conjugation system by a splicing
variant, NUB1L. J Biol Chem. 278:32905–32913. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tanji K, Tanaka T and Kamitani T:
Interaction of NUB1 with the proteasome subunit S5a. Biochem
Biophys Res Commun. 337:116–120. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Groettrup M, Pelzer C, Schmidtke G and
Hofmann K: Activating the ubiquitin family: UBA6 challenges the
field. Trends Biochem Sci. 33:230–237. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bornstein G, Ganoth D and Hershko A:
Regulation of neddylation and deneddylation of cullin1 in SCFSkp2
ubiquitin ligase by F-box protein and substrate. Proc Natl Acad Sci
USA. 103:11515–11520. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hosono T, Tanaka T, Tanji K, Nakatani T
and Kamitani T: NUB1, an interferon-inducible protein, mediates
anti-proliferative actions and apoptosis in renal cell carcinoma
cells through cell-cycle regulation. Br J Cancer. 102:873–882.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu B, Al-Ramahi I, Valencia A, Wang Q,
Berenshteyn F, Yang H, Gallego-Flores T, Ichcho S, Lacoste A, Hild
M, et al: Identification of NUB1 as a suppressor of mutant
Huntington toxicity via enhanced protein clearance. Nat Neurosci.
16:562–570. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kanaya K, Sohocki MM and Kamitani T:
Abolished interaction of NUB1 with mutant AIPL1 involved in Leber
congenital amaurosis. Biochem Biophys Res Commun. 317:768–773.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tanaka T, Nakatani T and Kamitani T:
Inhibition of NEDD8-conjugation pathway by novel molecules:
Potential approaches to anticancer therapy. Mol Oncol. 6:267–275.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Haas AL, Ahrens P, Bright PM and Ankel H:
Interferon induces a 15-kilodalton protein exhibiting marked
homology to ubiquitin. J Biol Chem. 262:11315–11323.
1987.PubMed/NCBI
|
|
36
|
Ichimura Y, Kirisako T, Takao T, Satomi Y,
Shimonishi Y, Ishihara N, Mizushima N, Tanida I, Kominami E, Ohsumi
M, et al: A ubiquitin-like system mediates protein lipidation.
Nature. 408:488–492. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rabut G and Peter M: Function and
regulation of protein neddylation. ‘Protein modifications: Beyond
the usual suspects’ review series. EMBO Rep. 9:969–976. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Walden H, Podgorski MS, Huang DT, Miller
DW, Howard RJ, Minor DL Jr, Holton JM and Schulman BA: The
structure of the APPBP1-UBA3-NEDD8-ATP complex reveals the basis
for selective ubiquitin-like protein activation by an E1. Mol Cell.
12:1427–1437. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Leidecker O, Matic I, Mahata B, Pion E and
Xirodimas DP: The ubiquitin E1 enzyme Ube1 mediates NEDD8
activation under diverse stress conditions. Cell cycle.
11:1142–1150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Olsen SK, Capili AD, Lu X, Tan DS and Lima
CD: Active site remodelling accompanies thioester bond formation in
the SUMO E1. Nature. 463:906–912. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang DT, Hunt HW, Zhuang M, Ohi MD,
Holton JM and Schulman BA: Basis for a ubiquitin-like protein
thioester switch toggling E1-E2 affinity. Nature. 445:394–398.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Huang DT, Ayrault O, Hunt HW, Taherbhoy
AM, Duda DM, Scott DC, Borg LA, Neale G, Murray PJ, Roussel MF and
Schulman BA: E2-RING expansion of the NEDD8 cascade confers
specificity to cullin modification. Mol Cell. 33:483–495. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kamura T, Conrad MN, Yan Q, Conaway RC and
Conaway JW: The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase
activates Rub1 modification of cullins Cdc53 and Cul2. Genes Dev.
13:2928–2933. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Enchev RI, Schulman BA and Peter M:
Protein neddylation: Beyond cullin-RING ligases. Nat Rev Mol Cell
Biol. 16:30–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hjerpe R, Thomas Y, Chen J, Zemla A,
Curran S, Shpiro N, Dick LR and Kurz T: Changes in the ratio of
free NEDD8 to ubiquitin triggers NEDDylation by ubiquitin enzymes.
Biochem J. 441:927–936. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Saha A and Deshaies RJ: Multimodal
activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol
Cell. 32:21–31. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chan Y, Yoon J, Wu JT, Kim HJ, Pan KT, Yim
J and Chien CT: DEN1 deneddylates non-cullin proteins in vivo. J
Cell Sci. 121:3218–3223. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gong N, Li XY, Xiao Q and Wang YX:
Identification of a novel spinal dorsal horn astroglial D-amino
acid oxidase-hydrogen peroxide pathway involved in morphine
antinociceptive tolerance. Anesthesiology. 120:962–975. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lyapina S, Cope G, Shevchenko A, Serino G,
Tsuge T, Zhou C, Wolf DA, Wei N, Shevchenko A and Deshaies RJ:
Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome.
Science. 292:1382–1385. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mendoza HM, Shen LN, Botting C, Lewis A,
Chen J, Ink B and Hay RT: NEDP1, a highly conserved cysteine
protease that deNEDDylates Cullins. J Biol Chem. 278:25637–25643.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Schwechheimer C, Serino G, Callis J,
Crosby WL, Lyapina S, Deshaies RJ, Gray WM, Estelle M and Deng XW:
Interactions of the COP9 signalosome with the E3 ubiquitin ligase
SCFTIRI in mediating auxin response. Science. 292:1379–1382. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Goldenberg SJ, Cascio TC, Shumway SD,
Garbutt KC, Liu J, Xiong Y and Zheng N: Structure of the
Cand1-Cul1-Roc1 complex reveals regulatory mechanisms for the
assembly of the multisubunit cullin-dependent ubiquitin ligases.
Cell. 119:517–528. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liu J, Furukawa M, Matsumoto T and Xiong
Y: NEDD8 modification of CUL1 dissociates p120 (CAND1), an
inhibitor of CUL1-SKP1 binding and SCF ligases. Mol Cell.
10:1511–1518. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Duda DM, Borg LA, Scott DC, Hunt HW,
Hammel M and Schulman BA: Structural insights into NEDD8 activation
of cullin-RING ligases: Conformational control of conjugation.
Cell. 134:995–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Morimoto M, Nishida T, Nagayama Y and
Yasuda H: Nedd8-modification of Cul1 is promoted by Roc1 as a
Nedd8-E3 ligase and regulates its stability. Biochem Biophys Res
Commun. 301:392–398. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Osaka F, Kawasaki H, Aida N, Saeki M,
Chiba T, Kawashima S, Tanaka K and Kato S: A new NEDD8-ligating
system for cullin-4A. Genes Dev. 12:2263–2268. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Podust VN, Brownell JE, Gladysheva TB, Luo
RS, Wang C, Coggins MB, Pierce JW, Lightcap ES and Chau V: A Nedd8
conjugation pathway is essential for proteolytic targeting of
p27Kip1 by ubiquitination. Proc Natl Acad Sci USA. 97:4579–4584.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Read MA, Brownell JE, Gladysheva TB,
Hottelet M, Parent LA, Coggins MB, Pierce JW, Podust VN, Luo RS,
Chau V and Palombella VJ: Nedd8 modification of cul-1 activates SCF
(beta (TrCP))-dependent ubiquitination of IkappaBalpha. Mol Cell
Biol. 20:2326–2333. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wada H, Yeh ET and Kamitani T:
Identification of NEDD8-conjugation site in human cullin-2. Biochem
Biophys Res Commun. 257:100–105. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kim W, Bennett EJ, Huttlin EL, Guo A, Li
J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, et al: Systematic
and quantitative assessment of the ubiquitin-modified proteome. Mol
Cell. 44:325–340. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Jeram SM, Srikumar T, Zhang XD, Eisenhauer
H Anne, Rogers R, Pedrioli PG, Matunis M and Raught B: An improved
SUMmOn-based methodology for the identification of ubiquitin and
ubiquitin-like protein conjugation sites identifies novel
ubiquitin-like protein chain linkages. Proteomics. 10:254–265.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
van der Veen AG and Ploegh HL:
Ubiquitin-like proteins. Annu Rev Biochem. 81:323–357. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
McLarnon A: Cancer: Mdm2-regulated
stabilization of HuR by neddylation in HCC and colon cancer-a
possible target for therapy. Nat Rev Gastroenterol Hepatol.
9:42011. View Article : Google Scholar
|
|
64
|
Ryu JH, Li SH, Park HS, Park JW, Lee B and
Chun YS: Hypoxia-inducible factor alpha subunit stabilization by
NEDD8 conjugation is reactive oxygen species-dependent. J Biol
Chem. 286:6963–6970. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Freiberg RA, Hammond EM, Dorie MJ, Welford
SM and Giaccia AJ: DNA damage during reoxygenation elicits a
Chk2-dependent checkpoint response. Mol Cell Biol. 26:1598–1609.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Ma T, Chen Y, Zhang F, Yang CY, Wang S and
Yu X: RNF111-dependent neddylation activates DNA damage-induced
ubiquitination. Mol Cell. 49:897–907. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Le Moan N, Houslay DM, Christian F,
Houslay MD and Akassoglou K: Oxygen-dependent cleavage of the p75
neurotrophin receptor triggers stabilization of HIF-1α. Mol Cell.
44:476–490. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Pawlus MR, Wang L and Hu CJ: STAT3 and
HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and
RCC4 cells. Oncogene. 33:1670–1679. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Choo YS, Vogler G, Wang D, Kalvakuri S,
Iliuk A, Tao WA, Bodmer R and Zhang Z: Regulation of parkin and
PINK1 by neddylation. Hum Mol Genet. 21:2514–2523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kandala S, Kim IM and Su H: Neddylation
and deneddylation in cardiac biology. Am J Cardiovasc Dis.
4:140–158. 2014.PubMed/NCBI
|
|
71
|
Abida WM, Nikolaev A, Zhao W, Zhang W and
Gu W: FBXO11 promotes the Neddylation of p53 and inhibits its
transcriptional activity. J Biol Chem. 282:1797–1804. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Noguchi K, Okumura F, Takahashi N, Kataoka
A, Kamiyama T, Todo S and Hatakeyama S: TRIM40 promotes neddylation
of IKKγ and is downregulated in gastrointestinal cancers.
Carcinogenesis. 32:995–1004. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Cao X and Sudhof TC: A transcriptionally
[correction of transcriptively] active complex of APP with Fe65 and
histone acetyltransferase Tip60. Science. 293:115–120. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Lee MR, Lee D, Shin SK, Kim YH and Choi
CY: Inhibition of APP intracellular domain (AICD) transcriptional
activity via covalent conjugation with Nedd8. Biochem Biophys Res
Commun. 366:976–981. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Theng SS, Wang W, Mah WC, Chan C, Zhuo J,
Gao Y, Qin H, Lim L, Chong SS, Song J and Lee CG: Disruption of
FAT10-MAD2 binding inhibits tumor progression. Proc Natl Acad Sci
USA. 111:E5282–E5291. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Michel L, Diaz-Rodriguez E, Narayan G,
Hernando E, Murty VV and Benezra R: Complete loss of the tumor
suppressor MAD2 causes premature cyclin B degradation and mitotic
failure in human somatic cells. Proc Natl Acad Sci USA.
101:4459–4464. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Tapia C, Kutzner H, Mentzel T, Savic S,
Baumhoer D and Glatz K: Two mitosis-specific antibodies, MPM-2 and
phospho-histone H3 (Ser28), allow rapid and precise determination
of mitotic activity. Am J Surg Pathol. 30:83–89. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wagenaar-Miller RA, Gorden L and Matrisian
LM: Matrix metalloproteinases in colorectal cancer: Is it worth
talking about? Cancer Metastasis Rev. 23:119–135. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Aichem A, Kalveram B, Spinnenhirn V, Kluge
K, Catone N, Johansen T and Groettrup M: The proteomic analysis of
endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of
FAT10ylation. J Cell Sci. 125:4576–4585. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Gao Y, Theng SS, Zhuo J, Teo WB, Ren J and
Lee CG: FAT10, an ubiquitin-like protein, confers malignant
properties in non-tumorigenic and tumorigenic cells.
Carcinogenesis. 35:923–934. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Lukasiak S, Schiller C, Oehlschlaeger P,
Schmidtke G, Krause P, Legler DF, Autschbach F, Schirmacher P,
Breuhahn K and Groettrup M: Proinflammatory cytokines cause FAT10
upregulation in cancers of liver and colon. Oncogene. 27:6068–6074.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Pelzer C, Kassner I, Matentzoglu K, Singh
RK, Wollscheid HP, Scheffner M, Schmidtke G and Groettrup M:
UBE1L2, a novel E1 enzyme specific for ubiquitin. J Biol Chem.
282:23010–23014. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Jin J, Li X, Gygi SP and Harper JW: Dual
E1 activation systems for ubiquitin differentially regulate E2
enzyme charging. Nature. 447:1135–1138. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Chiu YH, Sun Q and Chen ZJ: E1-L2
activates both ubiquitin and FAT10. Mol Cell. 27:1014–1023. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Aichem A, Pelzer C, Lukasiak S, Kalveram
B, Sheppard PW, Rani N, Schmidtke G and Groettrup M: USE1 is a
bispecific conjugating enzyme for ubiquitin and FAT10, which
FAT10ylates itself in cis. Nat Commun. 1:132010. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Hipp MS, Kalveram B, Raasi S, Groettrup M
and Schmidtke G: FAT10, a ubiquitin-independent signal for
proteasomal degradation. Mol Cell Biol. 25:3483–3491. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Hipp MS, Raasi S, Groettrup M and
Schmidtke G: NEDD8 ultimate buster-1L interacts with the
ubiquitin-like protein FAT10 and accelerates its degradation. J
Biol Chem. 279:16503–16510. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Ren J, Kan A, Leong SH, Ooi LL, Jeang KT,
Chong SS, Kon OL and Lee CG: FAT10 plays a role in the regulation
of chromosomal stability. J Biol Chem. 281:11413–11421. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Merbl Y, Refour P, Patel H, Springer M and
Kirschner MW: Profiling of ubiquitin-like modifications reveals
features of mitotic control. Cell. 152:1160–1172. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Gong P, Canaan A, Wang B, Leventhal J,
Snyder A, Nair V, Cohen CD, Kretzler M, D'Agati V, Weissman S and
Ross MJ: The ubiquitin-like protein FAT10 mediates NF-kappaB
activation. J Am Soc Nephrol. 21:316–326. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Bjorkoy G, Lamark T, Brech A, Outzen H,
Perander M, Overvatn A, Stenmark H and Johansen T: p62/SQSTM1 forms
protein aggregates degraded by autophagy and has a protective
effect on huntingtin-induced cell death. J Cell Biol. 171:603–614.
2005. View Article : Google Scholar : PubMed/NCBI
|
